Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Expert Opinion on Emerging Drugs|April 12, 2018
Emerging drugs for primary progressive multiple sclerosisRam Narendra Narayan, Thomas Forsthuber, Olaf StüveExpert Review of Clinical Immunology|December 20, 2014
Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the futureItay Raphael, Johanna Webb, Olaf Stuve, et al.Expert Review of Clinical Immunology|March 17, 2016
Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsisPatrick Ketter, Jieh-Juen Yu, Andrew P Cap, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 31, 2017
B-cell-targeted therapies in relapsing forms of MSDivyanshu Dubey, Thomas Forsthuber, Eoin P Flanagan, et al.Methodsx|September 21, 2019
A modified method for rapid quantification of <i>Chlamydia muridarum</i> using FluorospotJonathon Keck, James P Chambers, Thomas Forsthuber, et al.Archivum Immunologiae Et Therapiae Experimentalis|December 4, 2004
Macrophage migration inhibitory factor and its role in autoimmune diseasesClaudia M Denkinger, Christine Metz, Günter Fingerle-Rowson, et al.Frontiers in Immunology|December 5, 2022
Insights into <i>Acinetobacter baumannii</i> protective immunitySean Jeffreys, James P Chambers, Jieh-Juen Yu, et al.Journal of Neuroimmunology|January 1, 2003
Autoreactive T cells promote post-traumatic healing in the central nervous systemHarald H Hofstetter, Diane L Sewell, Frances Liu, et al.The Journal of Biological Chemistry|October 30, 2016
Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing PotentialJoshua Bloom, Christine Metz, Saisha Nalawade, et al.Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MSMichel Varrin-Doyer, Aparna Shetty, Collin M Spencer, et al.Pageof 2